Literature DB >> 9846551

ONYX-015: clinical data are encouraging.

D Kirn, T Hermiston, F McCormick.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9846551     DOI： 10.1038/3902

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  41 in total

Review 1.  Replication-selective adenoviruses as oncolytic agents.

Authors:  C Heise; D H Kirn
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 2.  Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?

Authors:  B R Dix; S J Edwards; A W Braithwaite
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 3.  Human papillomavirus therapy for the prevention and treatment of cervical cancer.

Authors:  Samir N Khleif
Journal:  Curr Treat Options Oncol       Date:  2003-04

Review 4.  Bugs as drugs for cancer.

Authors:  Eleanor J Cheadle; Andrew M Jackson
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

5.  Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants.

Authors:  Byron Hann; Allan Balmain
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 6.  Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma.

Authors:  Yi-Gang Wang; Pan-Pan Huang; Rong Zhang; Bu-Yun Ma; Xiu-Mei Zhou; Yan-Fang Sun
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

7.  Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas.

Authors:  Hong Jiang; Candelaria Gomez-Manzano; Ramon Alemany; Diana Medrano; Marta Alonso; B Nebiyou Bekele; E Lin; Charles C Conrad; W K Alfred Yung; Juan Fueyo
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

8.  Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy.

Authors:  K Doronin; M Kuppuswamy; K Toth; A E Tollefson; P Krajcsi; V Krougliak; W S Wold
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

9.  Synergistic induction of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying TRAIL.

Authors:  Qiuwei Pan; Bisheng Liu; Jin Liu; Rong Cai; Yigang Wang; Cheng Qian
Journal:  Mol Cell Biochem       Date:  2007-06-19       Impact factor: 3.396

Review 10.  The first 30 years of p53: growing ever more complex.

Authors:  Arnold J Levine; Moshe Oren
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.